is tirzepatide a glp-1 or glp 2 Who Qualifies for Medical Weight Loss Treatment? GLP-2 Frontier Peptide Labs

Not alwaysyour provider will determine if medication is appropriate based on your health and goals

Hair loss has been reported by some patients taking GLP-1 medications, but it is not considered a common side effect

MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A

doi: 10.1021/acschemneuro.4c00729